No details have been posted yet, but the House Oversight Committee will be holding a hearing on September 17: “Tiversa, Inc.: White Knight or Hi-Tech Protection Racket?”
The hearing will presumably include Tiversa’s role in obtaining and providing information to the FTC that it used in developing its complaint against LabMD.
PHIprivacy.net emailed Tiversa’s CEO to request a statement about the hearing but has received no reply as yet. Stay tuned….